9
Nov
2027
Italfarmaco S.p.A (Chemi, Lacer, Effik)
About Italfarmaco S.p.A (Chemi, Lacer, Effik)
Categories
Meet us at
-
CPHI Frankfurt 2027
Messe, Frankfurt
9 - 11 November 2027stand 80G13
-
Country/Region:Italy
-
On CPHI since:2022
-
Employees:1000 - 4999
Company types
Contact info
-
-
330 Viale Fulvio Testi, 20126, Milano, Italy
.jpg)
Italfarmaco S.p.A (Chemi, Lacer, Effik) Resources (2)
-
News Italfarmaco Acquires 100% of Lacer, a Spanish Pharmaceutical Company That Is a Leader in Health Care and Personal Hygiene
Thanks to this operation, that is subject to the approval of the competition authorities, the Group will reach 1,300 employees in Spain and 3,500 globally, with a consolidated turnover of over 1 billion euros.
Thanks to Lacer's 5 leading brands in Spain, Italfarmaco will become the most important player in Spain’s health and personal hygiene sectors
This merger represents an excellent opportunity for Italfarmaco's growth both in Spain and internationally
-
News Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy
Study meets primary endpoint with secondary and exploratory endpoints showing consistency with primary endpoint --
-- Data reinforces previously observed safety profile for Givinostat; treatment in boys with DMD continues to show a good tolerability profile --
-- The company is planning to discuss the potential for marketing application submission with regulatory authorities for Givinostat in DMD --
-- Results were presented at the Annual PPMD Conference on June 25, 2022 --